Adc Therapeutics Sa (ADCT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 261,338 | 250,867 | 278,598 | 326,441 | 466,544 |
| Receivables | 29,117 | 20,316 | 25,182 | 72,971 | 30,218 |
| Inventories | 4,184 | 2,251 | 16,177 | 12,073 | 11,122 |
| Other current assets | 6,084 | 9,450 | 5,990 | 23,495 | 17,298 |
| TOTAL | $306,335 | $291,254 | $336,291 | $434,980 | $525,182 |
| Non-Current Assets | |||||
| PPE Net | N/A | 5,075 | 5,622 | 3,355 | 4,066 |
| Investments And Advances | 0 | 0 | 1,647 | 7,613 | 41,236 |
| Intangibles | 0 | 0 | 0 | 0 | 13,582 |
| Other Non-Current Assets | 16,815 | 25,651 | 11,222 | 44,911 | 33,906 |
| TOTAL | $16,815 | $30,726 | $18,491 | $55,879 | $92,790 |
| Total Assets | $323,150 | $321,980 | $354,782 | $490,859 | $617,972 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 3,000 | N/A | N/A | N/A | 6,575 |
| Accounts payable and accrued liabilities | 9,175 | 18,029 | 15,569 | 12,351 | 12,080 |
| Accrued Expenses | 57,988 | 62,440 | 52,101 | 68,491 | N/A |
| Other current liabilities | N/A | N/A | N/A | N/A | 50,497 |
| TOTAL | $70,163 | $80,469 | $67,670 | $81,939 | $73,935 |
| Non-Current Liabilities | |||||
| Long Term Debt | 112,452 | 113,632 | 112,730 | 109,714 | N/A |
| Other Non-Current Liabilities | 326,369 | 330,521 | 322,631 | 219,755 | 377,949 |
| TOTAL | $438,821 | $444,153 | $435,361 | $329,469 | $377,949 |
| Total Liabilities | $508,984 | $524,622 | $503,031 | $411,408 | $451,884 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 127,044 | 99,084 | N/A | N/A | N/A |
| Common Shares | 11,080 | 8,425 | 7,312 | 7,312 | 6,445 |
| Retained earnings | -1,635,941 | -1,493,318 | -1,335,472 | -1,095,419 | -924,885 |
| Other shareholders' equity | -722 | -1,641 | 366 | 2,144 | 102,701 |
| TOTAL | $-185,834 | $-202,642 | $-148,249 | $79,451 | $166,088 |
| Total Liabilities And Equity | $323,150 | $321,980 | $354,782 | $490,859 | $617,972 |